The following column was originally published on Feb. 25, 2022. Thanks to breakthroughs in medicine and nutrition in recent years, we are living longer than ever before. But this increase in life ...

GSK is paying $80 million to ink a multi-target neurodegenerative pact with Flagship-founded Vesalius Therapeutics that ...

Under deal terms, GSK will give Vesalius Therapeutics $80 million in upfront and equity payments to identify treatments for ...

Sep. 24, 2024 — Parkinson's disease, a debilitating nervous system ... 2024 — Certain drugs commonly used to treat enlarged prostate may also decrease the risk for dementia with Lewy bodies ...

According to recent research, astrocyte cell transplantation could revolutionize treatments for neurological disorders such ...

Dexys Midnight Runners founding member Andy Leek has died aged 66 after a battle with Parkinson's disease. He died on ...

Common Degenerative Brain Disease May Begin to Develop in Middle ... In the future, the discovery may be used in treatment for Parkinson's ...

Nir Giladi from TAU’s Faculty of Medical and Health Sciences and the Tel Aviv Sourasky Medical Center, as well as other researchers from TAU and the University of Haifa. The study was backed by the ...

Clinical diagnosis of Parkinson's disease (PD ... agonist); add psychoactive drugs (clozapine, risperidone, quetiapine, valproate and lithium). Dysautonomia is a common occurrence in PD and ...

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced its financial results for the third quarter ended September 30, 2024.

A study of Gila monster venom helped start the revolution in weight-loss drugs. But scientists think that’s just the ...

Nov. 11, 2024 (GLOBE NEWSWIRE) -- via IBN – Annovis Bio, Inc. (NYSE: ANVS) ("Annovis" or the "Company"), a clinical-stage drug platform company developing novel therapies for neurodegenerative ...